valeant pharmaceuticals inte
(VRX:New York)
As of 8:04 PM 05/22/13 All times are local (Market data is delayed by at least 15 minutes).
Insiders at valeant pharmaceuticals inte (VRX)
| Name (Connections) | Board Relationships | Title | Type of Board Member | Age |
| J. Pearson | 22 Relationships | Chairman and Chief Executive Officer | -- | 52 |
| Howard Schiller | 138 Relationships | Chief Financial Officer, Principal Accounting Officer, Executive Vice President and Director | -- | 50 |
| H. Fibiger Ph.D. | 28 Relationships | Chairman of External Advisory Board, Chief Scientific Officer of Biovail Laboratories International SRL and Senior Vice President of Biovail Laboratories International SRL | -- | 69 |
Other Board Members on Board*
| Name (Connections) | Board Relationships | Type of Board Member | Primary Company | Age |
| Lloyd Segal | 32 Relationships | -- | Thallion Pharmaceuticals, Inc. | 48 |
| Robert Power | 16 Relationships | -- | Valeant Pharmaceuticals International, Inc. | 55 |
| Garrison Morfit CFA | 24 Relationships | -- | ValueAct Capital, LLC | 36 |
| Norma Provencio | 71 Relationships | -- | Beazer Homes USA Inc. | 54 |
| Robert Ingram | 194 Relationships | -- | Hatteras Venture Partners | 69 |
| Theodose Melas-Kyriazi | 22 Relationships | -- | SFW Capital Partners, LLC | 52 |
| Katharine Stevenson | 53 Relationships | -- | Nortel Networks Inc. | 50 |
| Mark Cochran Ph.D. | 37 Relationships | -- | Rivanna Pharmaceuticals Inc. | -- |
| Robert Lenox M.D. | 26 Relationships | -- | QRxPharma Limited | -- |
| Karoly Nikolich Ph.D. | 44 Relationships | -- | AGY Therapeutics, Inc. | -- |
| Kathleen Clarence-Smith M.D., Ph.D. | 21 Relationships | -- | Prestwick Chemical, Inc. | 65 |
| Ian Ragan Ph.D. | 16 Relationships | -- | Valeant Pharmaceuticals International, Inc. | -- |
| Franklin Berger CFA, BA, MA, MBA | 77 Relationships | -- | Thallion Pharmaceuticals, Inc. | 62 |
| Ronald Farmer | 68 Relationships | -- | Bank of Montreal | 61 |
*Data is at least as current as the most recent Definitive Proxy.
| Recently Viewed | |||
| VRX:US | $74.82 USD | -0.71 |  |
| Company | Last | Change |
| Actavis Inc | $130.04 USD | -0.16 |
| Allergan Inc/United States | $97.73 USD | -0.81 |
| Perrigo Co | $118.07 USD | -0.58 |
| Shire PLC | 2,122 GBp | -33.00 |
| Sun Pharmaceutical Industries Ltd | 1,000 INR | -1.95 |
| View Industry Companies | ||
Industry Analysis
VRX
Industry Average
| Valuation | VRX | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 6.1x |
|
| Price/Book | 6.4x |
|
| Price/Cash Flow | 28.9x |
|
| TEV/Sales | 3.2x |
|
Post a JobJobs
- Bridgewater, NJ | Valeant Pharmaceuticals InternationalPosted: May 07
- Bridgewater, NJ | Valeant PharmaceuticalsPosted: May 21
- Bridgewater, NJ | Valeant Pharmaceuticals InternationalPosted: May 06
- Bridgewater, NJ | Valeant PharmaceuticalsPosted: May 17
Sponsored Financial Commentaries
Sponsored Links
Report Data Issue
To contact VALEANT PHARMACEUTICALS INTE, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Please enter your information in the following field(s):
Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
